Notably, DHS administration did not improve the radiation-induced acute (10-day) hematopoietic and intestinal toxicities
Choose GHRP-2 if: You want GH stimulation without intense hunger GHRP-2's milder appetite effect makes it more practical for those who don't want to deal with powerful hunger surges You're combining with a GHRH analog Both peptides synergize equally well with CJC-1295 or Sermorelin, but GHRP-2's lower appetite impact makes the combination more comfortable You're lean and trying to stay lean Intense hunger can sabotage body composition goals You want the most studied diagnostic variant GHRP-2 has more clinical validation as a pituitary function test Choose GHRP-6 if: Appetite stimulation is a feature, not a bug Recovery from illness, post-surgery, cachexia, or deliberate caloric surplus goals benefit from GHRP-6's orexigenic effect You're interested in cytoprotective applications GHRP-6 has a more extensive literature on cardioprotection, neuroprotection, and tissue protection (GHRP-6 cardioprotection, 2024) You're underweight or struggling to eat enough The appetite boost can be therapeutic You want the historical "first" GHRP GHRP-6 has the longest research track record in the family Choose Neither (Consider Alternatives) if: You want minimal side effects Ipamorelin (most selective GHSR-1a agonist) You want maximum GH potency Hexarelin (strongest GHRP, but highest cortisol/prolactin)
Diacylfuroxans are masked nitrile oxides that inhibit GPX4 covalently
Blood 137 , 856859 (2021)
Timing Follow-up Marker A1c Why it matters Shows longer-term glucose control across both incretin and GH-axis pathways
What are the side effects I should actually worry about
